NxStage to Present at the Rodman & Renshaw Annual Global Investment Conference

LAWRENCE, Mass., Sept 09, 2010 /PRNewswire via COMTEX/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Robert S. Brown, Chief Financial Officer, will be presenting at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel, New York, NY.

NxStage’s investor presentation is scheduled for Tuesday, September 14th at 2:25 p.m. (ET). To listen to the audio webcast of the presentation during the event, please visit: https://www.nxstage.com/ and click on ‘Investor Information’.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at https://www.nxstage.com/.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Brown’s plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.

Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com

SOURCE NxStage Medical, Inc.